Treating multi drug resistant TB and HIV/AIDS in Manipur, India

Access to medicines

Unaffordable, unavailable, not adapted - people around the world face these challenges in accessing lifesaving medicines.

During the 1990s, MSF teams made a bitter observation: we were failing to treat some of our patients suffering from infectious diseases, while in developed countries, remarkable progress was being made in the field of health. Two decades on, medicines in developing countries are still either too expensive, aren't suitable to be used in many of the contexts in which we work (for example, in hot, humid conditions or where there's a lack of electricity), or simply don't exist for the diseases we need to treat.

In 1999, we launched the Campaign for Access to Essential Medicines, now known as the Access Campaign. Its mission focuses on three areas: overcoming barriers to access to essential medicines, stimulating research and development for neglected diseases, and promoting health exceptions to global trade agreements. In 2003, MSF joined several research institutes, including the Institut Pasteur, to create the Drugs for Neglected Diseases initiative (DNDi), a non-profit research and development organisation engaged in research and development of new treatments for neglected diseases.

 
Website

MSF Access Campaign

msfaccess.org
 
Sinethemba- MSF Treatment For TB in South Africa.
Tuberculosis

Fewer than five per cent of people in need are treated with new drugs

Press Release 23 Mar 2017
 
Journal article

Dilemmas in access to medicines: a humanitarian perspective

14 Mar 2017
Journal article
 
Medical care on the frontline - North Syria
Photo Story

Bringing aid close to the frontline

8 Mar 2017
Photo Story
 
Sara Ferrer, Medical Coordinator for Syria
Syria

The war has left tens of thousands of children unvaccinated

Voices from the Field 8 Mar 2017
 
Georgia: DR-TB patients find hope in new treatments
Georgia

endTB partnership launches clinical trial to target toughest strains of tuberculosis

Statement 6 Mar 2017
 
Sign language training and TB support in Swaziland
Eswatini (formerly Swaziland)

For patients with XDR-TB, treatment is a gruelling journey with severe side effects

Voices from the Field 27 Feb 2017
 
Journal article

When free is not fair: the case of vaccine donations

31 Jan 2017
Journal article
 
Internally displaced People form Taiz Enclave Yemen
Yemen

“Word had spread that I was a doctor, and people came to me for help all the time”

Voices from the Field 30 Jan 2017
 
Georgia: DR-TB patients find hope in new treatments
Access to medicines

Public health groups welcome agreement for development of promising new TB drug

Press Release 26 Jan 2017
Up Next
30 August 2019